Back
Blueprint Biosecurity Programs
webCredibility Rating
4/5
High(4)High quality. Established institution or organization with editorial oversight and accountability.
Rating inherited from publication venue: Blueprint Biosecurity
Blueprint Biosecurity is a nonprofit relevant to AI safety discussions around biosecurity risks, particularly as AI capabilities increasingly lower barriers to biological threat creation; their programs address governance and technical safeguards.
Metadata
Importance: 42/100homepage
Summary
Blueprint Biosecurity is an organization focused on reducing biological risks through policy advocacy, technical research, and capacity building. Their programs page outlines initiatives aimed at improving biosecurity governance, pandemic preparedness, and biosafety standards. The organization works at the intersection of science and policy to address both natural and engineered biological threats.
Key Points
- •Focuses on reducing catastrophic biological risks including engineered pandemics and bioweapons threats relevant to existential risk reduction
- •Engages in policy development and advocacy to strengthen biosecurity governance at national and international levels
- •Conducts technical research to inform biosecurity standards and detection/response capabilities
- •Works on biosafety and biosecurity capacity building to reduce dual-use research risks
- •Represents a civil society organization bridging scientific expertise and policy implementation in biosecurity
Cited by 1 page
| Page | Type | Quality |
|---|---|---|
| Blueprint Biosecurity | Organization | 60.0 |
Cached Content Preview
HTTP 200Fetched Apr 9, 20264 KB
Our Programs – Blueprint Biosecurity
Programs
Far-UVC
PPE
Glycol vapors
Funded Projects
Calls for Proposals
Publications
News
Team
Careers
Contact
Copyright © 2026 Blueprint Biosecurity - All Rights Reserved.
Privacy Policy & Cookies
Our Approach
The Problem
Despite the tremendous strides we have made against water-borne, food-borne, and vector-borne diseases, airborne infectious diseases remain one of humanity’s biggest challenges: The COVID-19 pandemic has claimed an estimated 27 million lives . Tuberculosis kills 1.6 million people annually . One billion people are infected by influenza every year, leading to millions of serious illnesses and hundreds of thousands of deaths.
Even after a global pandemic that spread largely via aerosols, tools to suppress the spread of airborne disease remain deeply neglected. This neglect is particularly concerning given the exceptional efficiency of airborne transmission in the wrong circumstances. The Omicron variant of SARS-CoV-2 demonstrated how rapidly airborne pathogens can spread, doubling cases approximately every 2-3 days and infecting an estimated 125 million people globally within just 10 weeks of its identification. Measles, the most infectious human pathogen, is also airborne.
Blueprint’s Priorities
Our work is currently divided primarily into two categories: collective protection and individual protection.
Our collective protection work focuses on identifying, investigating, and advancing the most promising interventions in the built environment that can minimize transmission of airborne pathogens. We divide this into technologies that can be adopted at scale both to prevent endemic disease and suppress novel outbreaks before they become pandemics, and technologies that are uniquely suited to mitigating a novel crisis.
Our individual protection work is dedicated to ensuring that critical workers have a sufficient supply of high quality reusable respirators in the event of a major airborne outbreak.
Our Programs
Far-UVC is a new form of germicidal UV light (GUV). Because it is strongly absorbed by proteins in the outer layer of human skin and eyes, it can inactivate a wide range of pathogens with minimal penetration into and effects on human tissues. This enables higher human exposure limits, unlocking the potential for disinfecting occupied spaces continuously while achieving significantly improved air cleaning over current alternatives. Far-UVC is also silent, energy efficient, commercially viable at scale, less vulnerable to engendering resistance than pharmaceuticals, and can be deployed in advance of an outbreak to help prevent a pandemic from occurring in the first place.
View Pr
... (truncated, 4 KB total)Resource ID:
85c8a9e1b2f87a38 | Stable ID: sid_geR7sOQ8R9